No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr1:161030000-161046200 |
Weak transcription |
ES-I3 Cell Line |
embryonic stem cell
|
2 |
chr1:161039600-161049000 |
Weak transcription |
Lung |
lung
|
3 |
chr1:161039600-161066800 |
Weak transcription |
Right Atrium |
heart
|
4 |
chr1:161039800-161049000 |
Weak transcription |
Fetal Intestine Small |
intestine
|
5 |
chr1:161039800-161052600 |
Weak transcription |
Rectal Mucosa Donor 31 |
rectum
|
6 |
chr1:161039800-161053000 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
7 |
chr1:161040000-161044400 |
Weak transcription |
Duodenum Mucosa |
Duodenum
|
8 |
chr1:161040200-161045000 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
9 |
chr1:161040200-161052600 |
Weak transcription |
Rectal Mucosa Donor 29 |
rectum
|
10 |
chr1:161040200-161052800 |
Weak transcription |
Colonic Mucosa |
Colon
|
11 |
chr1:161040800-161046800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
12 |
chr1:161041800-161043800 |
Enhancers |
H9 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
13 |
chr1:161042000-161044200 |
Weak transcription |
Pancreas |
Pancrea
|
14 |
chr1:161042000-161045000 |
Genic enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
15 |
chr1:161042000-161045000 |
Genic enhancers |
Esophagus |
oesophagus
|
16 |
chr1:161042000-161045000 |
Strong transcription |
Gastric |
stomach
|
17 |
chr1:161042000-161045000 |
Enhancers |
Placenta Amnion |
Placenta Amnion
|
18 |
chr1:161042200-161044400 |
Weak transcription |
K562 |
blood
|
19 |
chr1:161042400-161049400 |
Weak transcription |
Monocytes-CD14+_RO01746 |
blood
|
20 |
chr1:161043000-161046800 |
Enhancers |
HMEC |
breast
|
21 |
chr1:161043200-161044400 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
22 |
chr1:161043200-161044400 |
Enhancers |
NHEK |
skin
|
23 |
chr1:161043400-161043800 |
Enhancers |
Spleen |
Spleen
|
24 |
chr1:161043400-161044000 |
Flanking Bivalent TSS/Enh |
HepG2 |
liver
|
25 |
chr1:161043400-161044200 |
Active TSS |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
26 |
chr1:161043400-161044600 |
Active TSS |
HSMM |
muscle
|
27 |
chr1:161043400-161044800 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
28 |
chr1:161043400-161045000 |
Genic enhancers |
Stomach Mucosa |
stomach
|
29 |
chr1:161043400-161047000 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
30 |
chr1:161043600-161043800 |
Flanking Bivalent TSS/Enh |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
31 |
chr1:161043600-161044000 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
32 |
chr1:161043600-161044000 |
Transcr. at gene 5' and 3' |
Placenta |
Placenta
|
33 |
chr1:161043600-161045400 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
34 |
chr1:161043600-161052800 |
Weak transcription |
H1 Cell Line |
embryonic stem cell
|